PMC:7253233 / 13038-14620
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"444","span":{"begin":163,"end":176},"obj":"Gene"},{"id":"445","span":{"begin":178,"end":181},"obj":"Gene"},{"id":"446","span":{"begin":187,"end":221},"obj":"Gene"},{"id":"447","span":{"begin":223,"end":227},"obj":"Gene"},{"id":"448","span":{"begin":430,"end":434},"obj":"Gene"},{"id":"449","span":{"begin":452,"end":456},"obj":"Gene"},{"id":"450","span":{"begin":571,"end":575},"obj":"Gene"},{"id":"451","span":{"begin":20,"end":38},"obj":"Species"},{"id":"452","span":{"begin":284,"end":305},"obj":"Species"},{"id":"453","span":{"begin":306,"end":311},"obj":"Species"},{"id":"454","span":{"begin":1123,"end":1133},"obj":"Species"},{"id":"455","span":{"begin":1324,"end":1331},"obj":"Species"},{"id":"456","span":{"begin":1423,"end":1433},"obj":"Species"},{"id":"457","span":{"begin":256,"end":278},"obj":"Disease"},{"id":"458","span":{"begin":335,"end":350},"obj":"Disease"},{"id":"459","span":{"begin":863,"end":882},"obj":"Disease"},{"id":"460","span":{"begin":901,"end":909},"obj":"Disease"},{"id":"461","span":{"begin":921,"end":929},"obj":"Disease"},{"id":"462","span":{"begin":930,"end":939},"obj":"Disease"},{"id":"463","span":{"begin":993,"end":1005},"obj":"Disease"},{"id":"464","span":{"begin":1029,"end":1038},"obj":"Disease"},{"id":"465","span":{"begin":1094,"end":1106},"obj":"Disease"}],"attributes":[{"id":"A444","pred":"tao:has_database_id","subj":"444","obj":"Gene:3576"},{"id":"A445","pred":"tao:has_database_id","subj":"445","obj":"Gene:3576"},{"id":"A446","pred":"tao:has_database_id","subj":"446","obj":"Gene:6347"},{"id":"A447","pred":"tao:has_database_id","subj":"447","obj":"Gene:6347"},{"id":"A448","pred":"tao:has_database_id","subj":"448","obj":"Gene:20309"},{"id":"A449","pred":"tao:has_database_id","subj":"449","obj":"Gene:20296"},{"id":"A450","pred":"tao:has_database_id","subj":"450","obj":"Gene:20296"},{"id":"A451","pred":"tao:has_database_id","subj":"451","obj":"Tax:694009"},{"id":"A452","pred":"tao:has_database_id","subj":"452","obj":"Tax:11072"},{"id":"A453","pred":"tao:has_database_id","subj":"453","obj":"Tax:10090"},{"id":"A454","pred":"tao:has_database_id","subj":"454","obj":"Tax:2697049"},{"id":"A455","pred":"tao:has_database_id","subj":"455","obj":"Tax:9606"},{"id":"A456","pred":"tao:has_database_id","subj":"456","obj":"Tax:2697049"},{"id":"A457","pred":"tao:has_database_id","subj":"457","obj":"MESH:D018352"},{"id":"A458","pred":"tao:has_database_id","subj":"458","obj":"MESH:D001102"},{"id":"A459","pred":"tao:has_database_id","subj":"459","obj":"MESH:D001523"},{"id":"A460","pred":"tao:has_database_id","subj":"460","obj":"MESH:D012640"},{"id":"A461","pred":"tao:has_database_id","subj":"461","obj":"MESH:C000657245"},{"id":"A462","pred":"tao:has_database_id","subj":"462","obj":"MESH:D007239"},{"id":"A463","pred":"tao:has_database_id","subj":"463","obj":"MESH:D007249"},{"id":"A464","pred":"tao:has_database_id","subj":"464","obj":"MESH:D007239"},{"id":"A465","pred":"tao:has_database_id","subj":"465","obj":"MESH:D001778"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T74","span":{"begin":92,"end":101},"obj":"Body_part"},{"id":"T75","span":{"begin":131,"end":136},"obj":"Body_part"},{"id":"T76","span":{"begin":163,"end":176},"obj":"Body_part"},{"id":"T77","span":{"begin":187,"end":195},"obj":"Body_part"},{"id":"T78","span":{"begin":212,"end":219},"obj":"Body_part"},{"id":"T79","span":{"begin":331,"end":334},"obj":"Body_part"},{"id":"T80","span":{"begin":359,"end":368},"obj":"Body_part"},{"id":"T81","span":{"begin":373,"end":382},"obj":"Body_part"},{"id":"T82","span":{"begin":442,"end":445},"obj":"Body_part"},{"id":"T83","span":{"begin":515,"end":518},"obj":"Body_part"},{"id":"T84","span":{"begin":519,"end":524},"obj":"Body_part"},{"id":"T85","span":{"begin":535,"end":545},"obj":"Body_part"},{"id":"T86","span":{"begin":547,"end":554},"obj":"Body_part"},{"id":"T87","span":{"begin":560,"end":569},"obj":"Body_part"},{"id":"T88","span":{"begin":639,"end":644},"obj":"Body_part"},{"id":"T89","span":{"begin":645,"end":650},"obj":"Body_part"},{"id":"T90","span":{"begin":699,"end":704},"obj":"Body_part"},{"id":"T91","span":{"begin":712,"end":721},"obj":"Body_part"},{"id":"T92","span":{"begin":741,"end":746},"obj":"Body_part"},{"id":"T93","span":{"begin":747,"end":752},"obj":"Body_part"},{"id":"T94","span":{"begin":950,"end":969},"obj":"Body_part"},{"id":"T95","span":{"begin":1271,"end":1290},"obj":"Body_part"},{"id":"T96","span":{"begin":1406,"end":1409},"obj":"Body_part"}],"attributes":[{"id":"A74","pred":"fma_id","subj":"T74","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A75","pred":"fma_id","subj":"T75","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A76","pred":"fma_id","subj":"T76","obj":"http://purl.org/sig/ont/fma/fma264827"},{"id":"A77","pred":"fma_id","subj":"T77","obj":"http://purl.org/sig/ont/fma/fma62864"},{"id":"A78","pred":"fma_id","subj":"T78","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A79","pred":"fma_id","subj":"T79","obj":"http://purl.org/sig/ont/fma/fma55675"},{"id":"A80","pred":"fma_id","subj":"T80","obj":"http://purl.org/sig/ont/fma/fma54537"},{"id":"A81","pred":"fma_id","subj":"T81","obj":"http://purl.org/sig/ont/fma/fma68923"},{"id":"A82","pred":"fma_id","subj":"T82","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A83","pred":"fma_id","subj":"T83","obj":"http://purl.org/sig/ont/fma/fma55675"},{"id":"A84","pred":"fma_id","subj":"T84","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A85","pred":"fma_id","subj":"T85","obj":"http://purl.org/sig/ont/fma/fma54537"},{"id":"A86","pred":"fma_id","subj":"T86","obj":"http://purl.org/sig/ont/fma/fma54527"},{"id":"A87","pred":"fma_id","subj":"T87","obj":"http://purl.org/sig/ont/fma/fma68923"},{"id":"A88","pred":"fma_id","subj":"T88","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A89","pred":"fma_id","subj":"T89","obj":"http://purl.org/sig/ont/fma/fma50801"},{"id":"A90","pred":"fma_id","subj":"T90","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A91","pred":"fma_id","subj":"T91","obj":"http://purl.org/sig/ont/fma/fma62864"},{"id":"A92","pred":"fma_id","subj":"T92","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A93","pred":"fma_id","subj":"T93","obj":"http://purl.org/sig/ont/fma/fma50801"},{"id":"A94","pred":"fma_id","subj":"T94","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A95","pred":"fma_id","subj":"T95","obj":"http://purl.org/sig/ont/fma/fma20935"},{"id":"A96","pred":"fma_id","subj":"T96","obj":"http://purl.org/sig/ont/fma/fma20935"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T55","span":{"begin":131,"end":136},"obj":"Body_part"},{"id":"T56","span":{"begin":331,"end":334},"obj":"Body_part"},{"id":"T57","span":{"begin":515,"end":518},"obj":"Body_part"},{"id":"T58","span":{"begin":639,"end":658},"obj":"Body_part"},{"id":"T59","span":{"begin":639,"end":644},"obj":"Body_part"},{"id":"T60","span":{"begin":645,"end":650},"obj":"Body_part"},{"id":"T61","span":{"begin":741,"end":760},"obj":"Body_part"},{"id":"T62","span":{"begin":741,"end":746},"obj":"Body_part"},{"id":"T63","span":{"begin":747,"end":752},"obj":"Body_part"},{"id":"T64","span":{"begin":950,"end":969},"obj":"Body_part"},{"id":"T65","span":{"begin":1271,"end":1290},"obj":"Body_part"}],"attributes":[{"id":"A55","pred":"uberon_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A56","pred":"uberon_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"A57","pred":"uberon_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"A58","pred":"uberon_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/UBERON_0000120"},{"id":"A59","pred":"uberon_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A60","pred":"uberon_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"A61","pred":"uberon_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/UBERON_0000120"},{"id":"A62","pred":"uberon_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A63","pred":"uberon_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"A64","pred":"uberon_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"},{"id":"A65","pred":"uberon_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T111","span":{"begin":20,"end":24},"obj":"Disease"},{"id":"T112","span":{"begin":268,"end":281},"obj":"Disease"},{"id":"T113","span":{"begin":284,"end":305},"obj":"Disease"},{"id":"T114","span":{"begin":293,"end":305},"obj":"Disease"},{"id":"T115","span":{"begin":335,"end":350},"obj":"Disease"},{"id":"T116","span":{"begin":341,"end":350},"obj":"Disease"},{"id":"T117","span":{"begin":921,"end":929},"obj":"Disease"},{"id":"T118","span":{"begin":930,"end":939},"obj":"Disease"},{"id":"T119","span":{"begin":993,"end":1005},"obj":"Disease"},{"id":"T120","span":{"begin":1029,"end":1038},"obj":"Disease"},{"id":"T121","span":{"begin":1094,"end":1106},"obj":"Disease"},{"id":"T122","span":{"begin":1123,"end":1131},"obj":"Disease"},{"id":"T123","span":{"begin":1423,"end":1431},"obj":"Disease"}],"attributes":[{"id":"A111","pred":"mondo_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A112","pred":"mondo_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0019209"},{"id":"A114","pred":"mondo_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A116","pred":"mondo_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A117","pred":"mondo_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A118","pred":"mondo_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A119","pred":"mondo_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0001531"},{"id":"A122","pred":"mondo_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A123","pred":"mondo_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T163","span":{"begin":111,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T164","span":{"begin":131,"end":136},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T165","span":{"begin":131,"end":136},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T166","span":{"begin":178,"end":181},"obj":"http://purl.obolibrary.org/obo/CLO_0053704"},{"id":"T167","span":{"begin":187,"end":195},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T168","span":{"begin":234,"end":236},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T169","span":{"begin":239,"end":240},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T170","span":{"begin":282,"end":283},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T171","span":{"begin":306,"end":311},"obj":"http://purl.obolibrary.org/obo/CLO_0007836"},{"id":"T172","span":{"begin":331,"end":334},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T173","span":{"begin":331,"end":334},"obj":"http://www.ebi.ac.uk/efo/EFO_0000908"},{"id":"T174","span":{"begin":331,"end":334},"obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"T175","span":{"begin":359,"end":368},"obj":"http://purl.obolibrary.org/obo/CL_0000127"},{"id":"T176","span":{"begin":373,"end":382},"obj":"http://purl.obolibrary.org/obo/CL_0000129"},{"id":"T177","span":{"begin":430,"end":434},"obj":"http://purl.obolibrary.org/obo/CLO_0053704"},{"id":"T178","span":{"begin":515,"end":518},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T179","span":{"begin":515,"end":518},"obj":"http://www.ebi.ac.uk/efo/EFO_0000908"},{"id":"T180","span":{"begin":515,"end":518},"obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"T181","span":{"begin":519,"end":524},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T182","span":{"begin":535,"end":545},"obj":"http://purl.obolibrary.org/obo/CL_0000127"},{"id":"T183","span":{"begin":560,"end":569},"obj":"http://purl.obolibrary.org/obo/CL_0000129"},{"id":"T184","span":{"begin":639,"end":644},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T185","span":{"begin":639,"end":644},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T186","span":{"begin":645,"end":650},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"T187","span":{"begin":645,"end":650},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T188","span":{"begin":699,"end":704},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T189","span":{"begin":712,"end":721},"obj":"http://purl.obolibrary.org/obo/CL_0000576"},{"id":"T190","span":{"begin":741,"end":746},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T191","span":{"begin":741,"end":746},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"},{"id":"T192","span":{"begin":747,"end":752},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"T193","span":{"begin":747,"end":752},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T194","span":{"begin":762,"end":764},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T195","span":{"begin":790,"end":791},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T196","span":{"begin":1132,"end":1136},"obj":"http://purl.obolibrary.org/obo/CLO_0001236"},{"id":"T197","span":{"begin":1231,"end":1232},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T198","span":{"begin":1350,"end":1351},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T199","span":{"begin":1404,"end":1405},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T200","span":{"begin":1414,"end":1418},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T29","span":{"begin":178,"end":181},"obj":"Chemical"},{"id":"T30","span":{"begin":212,"end":219},"obj":"Chemical"},{"id":"T31","span":{"begin":430,"end":432},"obj":"Chemical"}],"attributes":[{"id":"A29","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_138181"},{"id":"A30","pred":"chebi_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A32","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T5","span":{"begin":145,"end":154},"obj":"http://purl.obolibrary.org/obo/GO_0009056"},{"id":"T6","span":{"begin":335,"end":350},"obj":"http://purl.obolibrary.org/obo/GO_0016032"},{"id":"T7","span":{"begin":993,"end":1005},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T80","span":{"begin":293,"end":305},"obj":"Phenotype"},{"id":"T81","span":{"begin":901,"end":909},"obj":"Phenotype"},{"id":"T82","span":{"begin":1094,"end":1106},"obj":"Phenotype"}],"attributes":[{"id":"A80","pred":"hp_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/HP_0002383"},{"id":"A81","pred":"hp_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/HP_0001250"},{"id":"A82","pred":"hp_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/HP_0003256"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T98","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"T99","span":{"begin":239,"end":451},"obj":"Sentence"},{"id":"T100","span":{"begin":452,"end":570},"obj":"Sentence"},{"id":"T101","span":{"begin":571,"end":766},"obj":"Sentence"},{"id":"T102","span":{"begin":767,"end":940},"obj":"Sentence"},{"id":"T103","span":{"begin":941,"end":1230},"obj":"Sentence"},{"id":"T104","span":{"begin":1231,"end":1469},"obj":"Sentence"},{"id":"T105","span":{"begin":1470,"end":1582},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}
2_test
{"project":"2_test","denotations":[{"id":"32462412-28103598-75539783","span":{"begin":230,"end":232},"obj":"28103598"},{"id":"32462412-24051980-75539784","span":{"begin":234,"end":236},"obj":"24051980"},{"id":"32462412-28103598-75539785","span":{"begin":447,"end":449},"obj":"28103598"},{"id":"32462412-24051980-75539786","span":{"begin":762,"end":764},"obj":"24051980"}],"text":"Previous studies of SARS-coronaviruses have described the proliferation of pro-inflammatory cytokines that are active in promoting blood–barrier breakdown, namely interleukin-8 (IL8) and monocyte chemoattractant protein-1 (MCP1) [10, 11]. A description of coronavirus infections in a Japanese encephalitis mouse model demonstrated CNS viral infection induced astrocyte and microglia proliferation, leading to increased release of IL-8 in the CSF [10]. MCP1 is another pro-inflammatory mediator that is expressed in CNS cells including astrocytes, neurons, and microglia. MCP1 may be up-regulated in conditions which target and degrade the blood–brain barrier and can recruit additional inflammatory cells as the monocytes migrate across the blood–brain barrier [11]. We hypothesize that as a result of the accumulation of inflammatory markers, there may be local cortical irritation that precipitates seizures related to COVID-19 infection. Although cerebrospinal fluid may contain markers of inflammation, the treatment of this infection is largely supportive, and with the additional risk of coagulopathy precipitated by SARS-CoV-2, a lumbar puncture may not be justifiable unless there is an alternative diagnosis to be sought. A limitation of our case series is that cerebrospinal fluid was unable to be obtained due to patient factors that made a lumbar puncture relatively contraindicated and that a CSF-PCR test for SARS-CoV-2 was not yet commercially available. As this disease continues to spread, we will continue to learn about its direct and/or indirect epileptogenesis."}